In Vitro Fixation of C3d and C5b-9 on Platelets by Human Platelet Reactive Antibodies
Overview
Authors
Affiliations
Most platelet-reactive autoantibodies and alloantibodies are not able to fix complement in vitro. However, exceptions have been found. These antibodies are usually characterized by the conventional platelet complement fixation test. A recently developed competitive enzyme immunoassay for quantitation of platelet-associated immunoglobulins and a modification thereof allowed the quantitative study of fixation of C3d and the membrane attack complex (C5b-9) on platelets by HLA antibodies, human platelet autoantibodies, and drug-dependent antibodies (ddab). The highest amounts of both complement products were fixed through ddabs, whereas autoantibodies only showed moderate complement fixation. This enzyme immunoassay is a valuable tool for the characterization of the complement-fixing properties of platelet-reactive antibodies.
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia.
Vayne C, Guery E, Rollin J, Baglo T, Petermann R, Gruel Y J Clin Med. 2020; 9(7).
PMID: 32668640 PMC: 7408966. DOI: 10.3390/jcm9072212.
Recent trends in platelet antigen/antibody detection.
MUELLER-ECKHARDT C, Kiefel V, Santoso S Blut. 1989; 59(1):35-43.
PMID: 2665871 DOI: 10.1007/BF00320246.
Nomura S, Yanabu M, Kido H, Fukuroi T, Yamaguchi K, Soga T Ann Hematol. 1991; 62(4):103-7.
PMID: 2031972 DOI: 10.1007/BF01702922.